Mon. May 25th, 2026
Spread the love

GerOut, Usain Bolt — GoutGout Is Not Going Anywhere

It’s Now Me, Noah Lyles, and the Others in the Sprinting Vanguard

When Usain Bolt retired, many believed the mantle of “fastest man alive” would become a rotating crown. But over the years, no one has come close to matching his 9.58 s world record — until now. The new generation, led by Noah Lyles and a cohort of rising sprinters, is staking their claim. GoutGout (a nickname or moniker used in some circles) may have had confidence, but the data says: the sprinting domain is not vacant.

In this article:

  1. A brief review of Bolt’s benchmark and legacy

  2. A look at Noah Lyles and key contenders in today’s 100 m field

  3. Comparative stats, predictions, and whether Bolt’s record is still safe


1. Bolt’s Benchmark: The Standard to Beat

  • Usain Bolt’s world record in the 100 m is 9.58 seconds, set at the Berlin World Championships in 2009. Wikipedia+3worldathletics.org+3worldathletics.org+3

  • That mark remains the fastest ever, even after adjusting for wind and altitude. Track & Field News+1

  • Bolt also ran 9.69, 9.72, and other sub-9.7 times in his career — setting a high ceiling for future sprinters to reach. Topend Sports+2worldathletics.org+2

  • In interviews, Bolt has suggested that with today’s high-tech “super spikes” he might have run even faster — some estimates he floated include 9.42 (though speculative). Sky Sports

Bolt’s legacy is not just his times, but also his dominance at championships, his showmanship, and psychological edge. Any emerging sprinter must measure not only in speed, but in consistency under pressure.


2. The New Generation: Noah Lyles & Co.

Noah Lyles

Lyles combines speed with strong championship composure, and his upward trajectory (as of 2025) makes him a central figure in the post-Bolt era. The Guardian


Other Top Contenders / Fast Sprinters Today

(While compiling a definitive “Top 20 today” is challenging due to active competition and seasonal fluctuations, below is a representative lineup of elite 100 m sprinters currently in the mix.)

Below is a sample list of prominent / fast men in the 100 m scene, with some known PBs or notable status (note: not all have fully filled bios available).

Athlete Nationality Known / Reported PB (100 m) Notes / Strengths
Noah Lyles USA 9.79 s Top medal performer, improving consistency
Oblique Seville Jamaica ~9.77 s (2025) Won 100 m in Tokyo 2025 Worlds with 9.77 s tdk.com+1
Fred Kerley USA ~9.81 s (medalist) Veteran with strong finishes in global finals
Christian Coleman USA 9.76 s (lifetime best) Among all-time fast times worldathletics.org+1
Ferdinand Omanyala Kenya 9.77 s (African record) Africa’s standout sprinter pulsesports.co.ke
Trayvon Bromell USA ~9.76–9.85 s (various) Injury-prone, but high peak potential pulsesports.co.ke
Justin Gatlin USA (retired) 9.74 s Historical rival to Bolt’s era worldathletics.org+2worldathletics.org+2
Yohan Blake Jamaica 9.69 s (career best) Bolt’s peer in Jamaican sprinting worldathletics.org+2worldathletics.org+2
Tyson Gay USA 9.69 s One of the fastest ever worldathletics.org
Asafa Powell Jamaica 9.72 s Known for consistent sub-10s performances Wikipedia+2worldathletics.org+2
(Others)

Because many sprinters’ current-season bests are subject to meet results, injury, or form, a full “Top 20 now” list would require up-to-date data from World Athletics or meet trackers.


3. Review & Comparative Analysis

Head-to-Head vs Bolt’s 9.58

  • None of the modern sprinters has officially come close to 9.58 s in competition.

  • Many top times are clustered in the 9.70s to low 9.80s range, indicating a performance gap still.

  • Bolt’s 9.58 remains an outlier — a historically exceptional performance, not just for one season but across multiple sub-9.7 runs.

Strengths & Weaknesses

  • Lyles: Strong acceleration phase, good top-end speed, and mental toughness in finals. Weakness might be the start (reaction) or sustaining full speed to finish.

  • Seville: Has shown he can deliver at global finals; his challenge is consistency.

  • Coleman: Outstanding pure speed in short distances but has struggled in championship events sometimes.

  • Omanyala, Bromell, Kerley: Great depth, but aging, injuries, or peak form timing are variable.

Prediction vs Bolt’s Time

  • It’s unlikely in the immediate future (next 3–5 years) that Bolt’s 9.58 will be broken in regular championship conditions. The margin is wide.

  • However, as equipment (spikes, track surfaces), training science, biomechanics, and genetics progress, a sub-9.58 is not impossible — just extremely hard.

  • Among the standouts, Noah Lyles is arguably the closest in potential to challenge the record, especially if he can shave off 0.15–0.20 seconds from his current best.

Predicted matchup: In a hypothetical “final vs Bolt’s best self,” the new generation would finish in the 9.6x to low-9.7 range. Bolt still wins, but margins narrow.


4. Conclusion & Takeaway

  • GoutGout, GerOut, or any challenger may express confidence — and confidence counts — but sprinting is data-driven.

  • The Bolt era still casts a long shadow; his 9.58 is a marker of elite exceptionalism.

  • But the baton (figuratively) is being passed: Noah Lyles and contemporaries are proving they can compete, medal, and push boundaries.

  • The future of the 100 m is deeper, more competitive, and more exciting. The record’s not guaranteed — but the chase is real.

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.